Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis

Introduction. Diabetic population has a higher risk of colorectal cancer (CRC) incidence and mortality than nondiabetics. The role of metformin in CRC prognosis is still controversial. The meta-analysis aims to investigate whether metformin improves the survival of diabetic CRC patients. Methods. Pu...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Fanqiang, Song, Li, Wang, Wenyue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320297/
https://www.ncbi.nlm.nih.gov/pubmed/28271076
http://dx.doi.org/10.1155/2017/5063239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320297/
https://www.ncbi.nlm.nih.gov/pubmed/28271076
http://dx.doi.org/10.1155/2017/5063239

Ejemplares similares